USPTO serial 85913863
SYMPHEOS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- FIRST, VIVIAN M
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SYMPHEOS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michele H. Bowman
MICHELE H. BOWMAN ABBOTT LABORATORIES100 ABBOTT PARK RDABBOTT PARK, IL 60064-3500UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Control and calibrating reagents for medical diagnostic instruments; control and calibrating reagents for laboratory instruments used for in vitro diagnostic testing and/or analysis; diagnostic reagents for scientific or medical research use; diagnostic test kits consisting primarily of monoclonal antibodies, antigens, buffers, assay components and reagents for scientific or medical laboratory use | ACTIVE | — |
| 005 | Biological reagents and chemical reagents for medical purposes; medical diagnostic assays for testing of bodily fluids and tissue in the detection, monitoring, and/or prediction of disease or other conditions, disease states, hormone level, drug level, drug response, organ function effectiveness, and/or clinical response; diagnostic preparations for medical purposes; diagnostic test kits comprised of medical diagnostic reagents and assays for testing in the field of medical diagnostics | ACTIVE | — |
| 009 | Research and commercial laboratory analyzers for measuring, testing and analyzing blood, bodily fluids and/or tissue; Laboratory instruments for in vitro diagnostic testing and/or analysis; Laboratory equipment for use in the field of medical diagnostics, namely, laboratory test and collection kits used in connection with in vitro diagnostics consisting of test tubes and microscope slides; Molecular diagnostic systems for the detection, quantitation, identification and functional analysis of nucleic acids, genetic materials, infectious agents and/or pathogens consisting of sequencers, spectrometers, sensors and computers; Automated clinical molecular instruments in the nature of sequencers, spectrometers, sensors and computers; Laboratory instruments for microbial screening and identification; Laboratory apparatus for genotyping, gene expression analysis, molecular imaging, and DNA sequence analysis; Laboratory test and collection kits used in connection with in vitro diagnostics comprising test tubes; Molecular diagnostic systems comprised of sequencers, spectrometers, sensors and computers, for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents or pathogens; automated clinical molecular laboratory instruments, namely, homogenizers; laboratory sample extraction instruments; laboratory instruments for microbial screening and identification; laboratory apparatus, namely, molecular diagnostic sensors for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; Data management and laboratory automation computer programs for use in the field of medical diagnostics; Computer hardware and software for use in the field of medical diagnostics; Data management software for medical diagnostic instruments; Data management software for hematology analyzers, clinical chemistry analyzers, immunoassay analyzers and blood screening instruments; Computer software and hardware for medical diagnostic instruments; Computer software and hardware for hematology analyzers, clinical chemistry analyzers, immunoassay analyzers and blood screening instruments; Computer software and hardware for managing interface between medical diagnostic laboratory instruments; Computer software and hardware for managing medical diagnostic laboratory workflow; Laboratory information management software and hardware for use in the field of medical diagnostics; Computer software and hardware for monitoring medical diagnostic instruments; Computer software and hardware for monitoring laboratory diagnostic instruments; Computer software and hardware for troubleshooting regarding medical diagnostic instruments; Computer software and hardware for troubleshooting regarding laboratory diagnostic instruments; Computer software for processing diagnostic medical testing data; Computer hardware and software for use in medical diagnostic testing; Computer hardware and software for remote monitoring of in vitro diagnostic instruments; Computer software and hardware for identification and analysis of nucleic acid sequences, nucleic acids for pathogen identity, drug resistance characteristics and forensic profiles; Computer software for front-end processing, instrument control, data analysis and reporting for molecular diagnostic instruments; Electronic publications, namely, instruction sheets and manuals for in vitro diagnostic instruments, laboratory automation systems recorded on computer media, and related software | ACTIVE | — |
| 010 | Hematology analyzers for medical diagnostic use; clinical chemistry analyzers for medical diagnostic use in testing bodily fluids; immunoassay analyzers for medical diagnostic use; blood screening instruments for medical use; medical diagnostic instruments for in vitro diagnostic testing and/or analysis; molecular diagnostic instruments for the analysis of body fluids; medical diagnostic instruments, namely, sample handlers, sample preparation equipment, equipment for testing bodily fluids for medical diagnosis; specimen collection kits used in connection with in vitro diagnostics comprising sample collection tubes all for medical use | ACTIVE | — |
| 042 | Providing technical support services regarding in vitro diagnostic laboratory instruments, laboratory automation systems, and related software and hardware, namely, troubleshooting in the nature of diagnosing problems with medical equipment; Providing technical support, namely, troubleshooting of problems in the field of laboratory software in the field of in vitro diagnostics; Providing remote electronic troubleshooting services for laboratories in the field of in vitro diagnostics; Providing operational monitoring services for laboratory equipment in the field of in vitro diagnostics; Remote monitoring of medical diagnostic laboratory systems to ensure proper functioning; Providing remote electronic monitoring of in vitro diagnostic equipment and laboratory automation systems to ensure proper functioning; Platform as a service (PAAS) featuring computer platform for laboratory and diagnostic equipment information management, monitoring and analysis in the field of in vitro diagnostics; Software as a service (SAAS) services featuring software for use in managing data and information in the field of medical diagnostics; Providing a website featuring instruction sheets and operating manuals for in vitro diagnostic instruments, laboratory automation systems, and related software | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Abbott Laboratories
- Other trademarks owned by Abbott Laboratories
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named SYMPHEOS
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 18, 2017 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 18, 2017 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 18, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 17, 2017 | EX5G | SOU EXTENSION 5 GRANTED | — |
| May 11, 2017 | EXT5 | SOU EXTENSION 5 FILED | — |
| May 11, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 6, 2016 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 5, 2016 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Nov 10, 2016 | EXT4 | SOU EXTENSION 4 FILED | — |
| Nov 10, 2016 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 20, 2016 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 19, 2016 | EX3G | SOU EXTENSION 3 GRANTED | — |
| May 10, 2016 | EXT3 | SOU EXTENSION 3 FILED | — |
| May 10, 2016 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 17, 2015 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 16, 2015 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Nov 9, 2015 | EXT2 | SOU EXTENSION 2 FILED | — |
| Nov 9, 2015 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 9, 2015 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 8, 2015 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 4, 2015 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 5, 2015 | EXT1 | SOU EXTENSION 1 FILED | — |
| May 5, 2015 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 11, 2014 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 16, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 16, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 27, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 8, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 7, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 6, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 5, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 5, 2014 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 5, 2014 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 5, 2014 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 5, 2014 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 8, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 8, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 6, 2014 | ALIE | ASSIGNED TO LIE | — |
| Dec 10, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 10, 2013 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 10, 2013 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 10, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 4, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| May 1, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 27, 2013 | NWAP | NEW APPLICATION ENTERED | — |